These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4862302)

  • 1. [Changes in the resistance to the toxicity of influenza virus injection in mice previously vaccinated with BCG. (1)].
    Suzuki T
    Nihon Saikingaku Zasshi; 1966 Dec; 21(12):707-10. PubMed ID: 4862302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the resistance to toxicity of intravenously injected influenza virus in mice with BCG vaccination. (2)].
    Suzuki T
    Nihon Saikingaku Zasshi; 1967 Jan; 22(1):5-9. PubMed ID: 6070069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of the effects of BCG and Corynebacterium parvum vaccines in experimental infection of mice with influenza virus. Foot pad test, splenic indicator and histologic changes in the thymus gland, spleen and lymph nodes].
    Ciebiada I; Błoch P; Kulig A; Denys A
    Med Dosw Mikrobiol; 1989; 41(2):92-9. PubMed ID: 2586194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro resistance to influenza virus infection of macrophages induced by BCG.
    Ganguly R; Czaruk KP; Spencer JC; Waldman RH
    Indian J Med Res; 1977 Dec; 66(6):889-94. PubMed ID: 611108
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased resistance to virus infections of mice inoculated with BCG (Bacillus calmette-guérin).
    Floc'h F; Werner GH
    Ann Immunol (Paris); 1976; 127(2):173-86. PubMed ID: 180868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of LSD on some immune processes and organ changes in mice infected with an influenza virus].
    Kocur J; Denys A; Szram S
    Med Dosw Mikrobiol; 1975; 27(1):85-8. PubMed ID: 1167925
    [No Abstract]   [Full Text] [Related]  

  • 8. Clearance of antibody and complement in serum after challenge of mice previously vaccinated or infected with influenza virus.
    Semkow R; Wilczyński J
    Acta Virol; 1979 May; 23(3):253-6. PubMed ID: 41439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.
    Crevar CJ; Ross TM
    Virol J; 2008 Oct; 5():131. PubMed ID: 18957098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on immunization of mice with influenza virus hemagglutinins].
    Moisa L; Stoian N
    Stud Cercet Inframicrobiol; 1971; 22(3):203-7. PubMed ID: 5128531
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
    Lipatov AS; Webby RJ; Govorkova EA; Krauss S; Webster RG
    J Infect Dis; 2005 Apr; 191(8):1216-20. PubMed ID: 15776365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
    Saluja V; Visser MR; Ter Veer W; van Roosmalen ML; Leenhouts K; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2010 Nov; 28(50):7963-9. PubMed ID: 20946860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus infection in mice: the effect of avirulent virus infection on the pathogenicity of highly virulent virus.
    Kurimura T; Hirano A; Suzuki N; Okuno Y
    Biken J; 1971 Mar; 14(1):65-73. PubMed ID: 5090680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Presence and reproduction of the influenza virus in the organs of white mice with an experimental infection. II. After intracerebral and intravenous applications].
    Necheva N; Manolova N
    Acta Microbiol Virol Immunol (Sofiia); 1977; 6():71-7. PubMed ID: 607787
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection and tissue localization of components of the immune complex in animals infected and immunized with influenza virus.
    Semkow R; Wilczyński J
    Acta Virol; 1979 Jan; 23(1):52-8. PubMed ID: 35959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice.
    Kleinerman ES; Daniels CA; Polisson RP; Snyderman R
    Am J Pathol; 1976 Nov; 85(2):373-82. PubMed ID: 11695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.